Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Sun Pharma Gains in Mumbai After Drug Gets Initial FDA Approval

Don't Miss Out —
Follow us on:

Dec. 31 (Bloomberg) -- Sun Pharmaceutical Industries Ltd. climbed in Mumbai trading after India’s largest drugmaker by market value said it received initial approval from the U.S. Food and Drug Administration for a copy of Roche Holding AG’s osteoporosis drug Boniva.

The stock rose 1.3 percent to 488.90 rupees as of 9:18 a.m. local time.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{SUNP IN <Equity> CN <GO>}

To contact the editor responsible for this story: Suresh Seshadri at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.